Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study
Status: Active_not_recruiting
Location: See all (4) locations...
Intervention Type: Device, Procedure
Study Type: Observational
SUMMARY
This study aims to assess the incidence of atrial fibrillation (AF), documented using data recorded by an implantable Holter monitoring device (Reveal Linq, Medtronic) within 2 years after percutaneous closure of patent foramen ovale for cryptogenic stroke.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult patients (aged \>18 years)
• with an indication for percutaneous closure of PFO due to cryptogenic stroke, with indication validated by a cardio-neurological team.
• patients must provide written informed consent
• patients must be affiliated to a social security regime or be a beneficiary thereof.
Locations
Other Locations
France
University Hospital Besancon
Besançon
CHU Lyon - Hôpital Louis Pradel
Bron
CHU Dijon
Dijon
CHU Grenoble
Grenoble
Time Frame
Start Date: 2021-07-05
Completion Date: 2025-12-31
Participants
Target number of participants: 250
Treatments
Patients planned for percutaneous PFO closure
Patients will undergo implantation of a Holter device (Reveal Linq Medtronic) 2 months prior to percutaneous PFO closure. Devices will be monitored by telemonitoring until the PFO closure procedure, and at 2, 12 and 24 months after the procedure.
Related Therapeutic Areas
Sponsors
Leads: Centre Hospitalier Universitaire de Besancon